Company Analysis

Traws Pharma, Inc. (TRAW)

Nasdaq: TRAW · Pharmaceutical Preparations · Newtown, PA · filing with the SEC since 2003
Grade4.3
◀ Past 2.8● Present 2.4▶ Future 7.0
1 est.

Who runs Traws Pharma, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Cautreels Werner
Chief Executive Officer. First filing Apr 2024, latest Jul 15, 2026, 0 filings in all.
Officers reporting now
6
of 10 people with a filing in the last fifteen months
Directors reporting now
4
29 people on the record since 2013
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Pauza Charles DavidChief Science Officer VirologyApr 2024Jul 16, 2026none
Cautreels WernerChief Executive OfficerApr 2024Jul 15, 2026none
Savchuk NikolayChief Operating OfficerApr 2024Jul 15, 2026none
Dukes Iain D.Chief Executive OfficerApr 2024Jul 14, 2026none
Parker Charles NolanChief Financial OfficerDec 2025Jul 14, 2026none
Redfield RobertChief Medical OfficerApr 2024Jul 14, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Clarke TrafforddirectorDec 2022Jul 14, 2026none
Leaman John HarolddirectorOct 2025Jul 14, 2026none
Shoemaker Mary TeresadirectorJun 2020Jul 14, 2026none
Stover Jack EdirectorMay 2016Jul 14, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Orbimed Advisors LLC10% ownerApr 2024Apr 28, 2026none
Orbimed Capital Gp Viii LLC10% ownerApr 2024Apr 28, 2026none
Earlier names on the record28, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton TRAW · research, not advice